Ambri Limited Monitoring & Testing
In 1998 AMBRI Limited obtained a worldwide exclusive license for sensing applications for the Ion Channel Switch™ (ICS) technology from the Cooperative Research Centre for Molecular Engineering and Technology. This device was the first purpose built nanomachine operating with moving parts that are nanometres in dimension. ICS is a nanoscale platform that forms a self-assembling bio-membrane, and acts as a biological switch capable of detecting chemical and biological substances in body fluid, foods and water. It is triggered when a target molecule and antibody fragments bind and alter the ion flow or conductivity across the synthetic bio-membrane.
No comments:
Post a Comment